Tower Research Capital (TRC)’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86.6K Buy
23,655
+20,228
+590% +$74K ﹤0.01% 2501
2025
Q1
$14.8K Buy
3,427
+3,003
+708% +$13K ﹤0.01% 3262
2024
Q4
$1.36K Sell
424
-7,597
-95% -$24.3K ﹤0.01% 5037
2024
Q3
$22.9K Sell
8,021
-1,530
-16% -$4.38K ﹤0.01% 3167
2024
Q2
$26.7K Buy
9,551
+8,880
+1,323% +$24.9K ﹤0.01% 3570
2024
Q1
$1.91K Sell
671
-5,992
-90% -$17K ﹤0.01% 5159
2023
Q4
$27.3K Buy
6,663
+3,235
+94% +$13.2K ﹤0.01% 3473
2023
Q3
$10.9K Sell
3,428
-1,490
-30% -$4.74K ﹤0.01% 4063
2023
Q2
$16.3K Buy
4,918
+868
+21% +$2.88K ﹤0.01% 3545
2023
Q1
$9K Sell
4,050
-3,973
-50% -$8.83K ﹤0.01% 4523
2022
Q4
$22K Sell
8,023
-75,296
-90% -$206K ﹤0.01% 3052
2022
Q3
$270K Buy
83,319
+19,823
+31% +$64.2K ﹤0.01% 1644
2022
Q2
$310K Buy
63,496
+16,024
+34% +$78.2K 0.01% 1456
2022
Q1
$362K Buy
47,472
+21,083
+80% +$161K ﹤0.01% 1349
2021
Q4
$244K Buy
26,389
+5,968
+29% +$55.2K ﹤0.01% 1612
2021
Q3
$291K Buy
20,421
+13,954
+216% +$199K 0.01% 1442
2021
Q2
$108K Buy
6,467
+3,758
+139% +$62.8K ﹤0.01% 2362
2021
Q1
$49K Buy
2,709
+619
+30% +$11.2K ﹤0.01% 3148
2020
Q4
$16K Sell
2,090
-19,430
-90% -$149K ﹤0.01% 4011
2020
Q3
$82K Buy
21,520
+16,303
+312% +$62.1K ﹤0.01% 3297
2020
Q2
$20K Buy
+5,217
New +$20K ﹤0.01% 3682
2020
Q1
Sell
-12,034
Closed -$58K 3651
2019
Q4
$58K Buy
+12,034
New +$58K ﹤0.01% 1244
2019
Q3
Sell
-1,133
Closed -$9K 4400
2019
Q2
$9K Buy
+1,133
New +$9K ﹤0.01% 2622
2018
Q4
Sell
-2,575
Closed -$26K 4203
2018
Q3
$26K Sell
2,575
-2,695
-51% -$27.2K ﹤0.01% 2169
2018
Q2
$53K Buy
5,270
+1,245
+31% +$12.5K ﹤0.01% 1825
2018
Q1
$40K Buy
4,025
+1,997
+98% +$19.8K ﹤0.01% 1795
2017
Q4
$20K Buy
2,028
+852
+72% +$8.4K ﹤0.01% 2072
2017
Q3
$12K Buy
+1,176
New +$12K ﹤0.01% 2993